Methodological Approaches to Evaluate the Impact of FDA Drug Safety Communications

• Aaron Seth KesselheimBrigham and Women's Hospital
• Eric G. CampbellHarvard University
• Sebastian SchneeweißBrigham and Women's Hospital
• Paula RauschUnited States Food and Drug Administration
• Brian M. LappinUnited States Food and Drug Administration
• Esther H. ZhouUnited States Food and Drug Administration
• John D. SeegerBrigham and Women's Hospital
• John S. BrownsteinBoston Children's Hospital
• Steven WoloshinDartmouth Institute for Health Policy and Clinical Practice
• Lisa M. SchwartzDartmouth Institute for Health Policy and Clinical Practice
• Timothy ToomeyBrigham and Women's Hospital
• Gerald J. Dal PanUnited States Food and Drug Administration
• Jerry AvornBrigham and Women's Hospital